Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arxan Technologies is a leading provider of application protection and cybersecurity solutions, specializing in anti-tamper and data protection for mobile, IoT, and desktop applications. The company is a key player in the healthcare sector, where it provides security for connected medical devices and mobile health (mHealth) applications to prevent reverse engineering and code tampering. Arxan's patented technology utilizes a multi-layered 'guard' network that includes code obfuscation, white-box cryptography, and runtime application self-protection (RASP). Founded in 2001 as a spin-off from Purdue University, the company's solutions are designed to ensure patient safety and regulatory compliance for life science organizations. In 2020, Arxan was acquired by Digital.ai, integrating its security suite into an intelligent value stream platform that serves global enterprises across multiple high-stakes industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arxan Technologies.